Stay updated on Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Sign up to get notified when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.

Latest updates to the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedUpgrade notice and operating-status information added (including a version bump to v3.2.0); the previous v3.1.0 reference was removed.SummaryDifference7%
- Check19 days agoChange DetectedPage updated to v3.1.0 with new study status/contacts/locations and date; prior v3.0.2 and 2025-07-22 removed.SummaryDifference1.0%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.4%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.4%
- Check48 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.SummaryDifference80%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.